Home

Eris Lifesciences Ltd EPS

Image

ERIS Lifesciences Ltd

NSE: ERIS

EPS

₹ 24.19

Last updated on: Apr 09, 2025

Key Highlights

  • The Earning per Share of ERIS Lifesciences Ltd is ₹ 24.19 as of 09 Apr 25 .
  • The earning per share of ERIS Lifesciences Ltd changed from ₹ 6.97 to ₹ 6.15 over 7 quarters. This represents a CAGR of -6.90% .

Historical Earning per Share of ERIS Lifesciences Ltd

No data available

* All values are in

Company Fundamentals for ERIS Lifesciences Ltd

Market Cap

18,573 Cr

EPS

24.2

P/E Ratio (TTM)

56.4

P/B Ratio (TTM)

6.7

Day’s High

1376.5

Day’s Low

1280.0

DTE

1.0

ROE

12.6

52 Week High

1593.0

52 Week Low

815.5

ROCE

11.0

Market Price of ERIS Lifesciences Ltd

1M

1Y

3Y

5Y

Monitoring ERIS Lifesciences Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
09 Apr 20251364.05
08 Apr 20251321.05
07 Apr 20251275.2
04 Apr 20251319.7
03 Apr 20251367.45
02 Apr 20251374.2
01 Apr 20251390.9
28 Mar 20251416.5
27 Mar 20251407.8
26 Mar 20251312.2

SWOT Analysis Of ERIS Lifesciences Ltd

Strength

4

che

Weakness

2

che

Opportunity

0

che

Threats

1

che

BlinkX Score for ERIS Lifesciences Ltd

Asset Value vs Market Value of ERIS Lifesciences Ltd

Market Value

18,573

Asset Value

Value addition

6.1 X

2,609

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
ERIS Lifesciences Ltd18573
Sun Pharmaceutical Industries Ltd396394
Divis Laboratories Ltd142920
Cipla Ltd114383
Torrent Pharmaceuticals Ltd105812
Mankind Pharma Ltd95481

Historical Market Cap of ERIS Lifesciences Ltd

No data available

* All values are in crore

Historical Revenue of ERIS Lifesciences Ltd

No data available

* All values are in crore

Historical EBITDA of ERIS Lifesciences Ltd

No data available

* All values are in crore

Historical Net Profit of ERIS Lifesciences Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

ERIS Lifesciences Ltd News Hub

ERIS Lifesciences to convene AGM

ERIS Lifesciences announced that the 18th Annual General Meeting (AGM) of the company will be held o

Read more

05 Aug 24

ERIS Lifesciences consolidated net profit declines 12.31% in the June 2024 quarter

Net profit of ERIS Lifesciences declined 12.31% to Rs 83.18 crore in the quarter ended June 2024 as

Read more

02 Aug 24

ERIS Lifesciences announces board meeting date

ERIS Lifesciences will hold a meeting of the Board of Directors of the Company on 25 October 2024. P

Read more

22 Oct 24

ERIS Lifesciences to hold board meeting

ERIS Lifesciences will hold a meeting of the Board of Directors of the Company on 4 February 2025. P

Read more

29 Jan 25

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

Aug 2024

PPT

June 2024

TranscriptPPT

Mar 2023

Transcript

Jan 2023

PPT

Oct 2022

PPT

Aug 2022

PPT

May 2022

PPT

Feb 2022

PPT

Aug 2021

PPT

July 2021

PPT

May 2021

PPT

Jan 2021

PPT

FAQs for EPS of ERIS Lifesciences Ltd

What is the EPS of ERIS Lifesciences Ltd stock?

The Earnings Per Share (EPS) of ERIS Lifesciences Ltd is 24.19. An EPS is the amount of net income attributed to each share of a common stock.

How is ERIS Lifesciences Ltd EPS calculated?

The EPS of ERIS Lifesciences Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does ERIS Lifesciences Ltd report its EPS?

ERIS Lifesciences Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence ERIS Lifesciences Ltd EPS?

Factors that influence the EPS of ERIS Lifesciences Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can ERIS Lifesciences Ltd EPS growth indicate future performance?

Yes, consistent growth in ERIS Lifesciences Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions